BioSpace News Archive

Nexodyn® AcidOxidizing Solution is now starting to be available in Saudi Arabia and United Arab Emirates (UAE), promoted and commercialized by the leading pharmaceutical company Cigalah Medpharm, part of Cigalah Group, following an exclusive partnership with the Swiss Pharma company APR Applied Pharma Research (“APR”).

Strategic Deal Extends and Diversifies Company’s Footprint in Life Science Research

Now Also Runs on PCs, Macs, and iPads

Rodin Therapeutics today announced the launch of a clinical trial to assess the performance of a new PET ligand that can measure synaptic density in the living brain.

First Product MZS Sleeping Aid™ Currently Expected to Launch in the U.S. in Q4 2018

Positive outcomes in proof-of-concept study with subcutaneous rozanolixizumab in patients with myasthenia gravis (MG): clinically meaningful improvement in multiple disease-related endpoints

Lunch Symposium to Highlight Use of Cytal Wound Matrix and MicroMatrix in Traumatic Wounds with Exposed Avascular Structures

Sonendo is experiencing exponential growth due to the market response for the GentleWave® Procedure – an alternative approach to standard root canal treatment.

RTI will host a conference call and simultaneous audio webcast to discuss third quarter 2018 results at 9:00 a.m. ET the same day.

RP-L102 Continues to Demonstrate Increasing and Durable Engraftment (Peripheral Vector Copy Number) In Fanconi Anemia Patients for Up to Thirty Months with First-Generation Process